Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed EBT Margin across 7 years of filings, most recently posting 159.9% for Q2 2026.

• In Q2 2026, EBT Margin rose 324.0% year-over-year to 159.9%; the TTM figure through Jun 2026 stood at 145.34% (up 22.0% YoY), while the FY2025 annual figure was 140.18%, up 2690.0% from the prior year.
• EBT Margin came in at 159.9% for Q2 2026 at Rapid Micro Biosystems, up from 178.29% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 110.65% in Q4 2025 to a low of 375.86% in Q4 2022.
• Average EBT Margin over 5 years is 221.78%, with a median of 184.06% recorded in 2026.
• Year-over-year, EBT Margin plunged 16229 bps in 2022 and jumped 19969 bps in 2023.
• Over 5 years, EBT Margin stood at 375.86% in 2022, then jumped by 53 bps to 176.17% in 2023, then surged by 33 bps to 117.73% in 2024, then gained by 6 bps to 110.65% in 2025, then tumbled by 45 bps to 159.9% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 159.9% in Q2 2026, 178.29% in Q1 2026, and 110.65% in Q4 2025.